Richard Zellars named chair of radiation oncology at IU School of Medicine

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

RICHARD ZELLARS was named professor and chair of radiation oncology at the Indiana University School of Medicine, pending approval by the IU trustees. He will begin his new duties in January.

Zellars is a breast cancer research and associate professor of radiation oncology at The Johns Hopkins University, and is assistant director of clinical trial accrual at the Sidney Kimmel Comprehensive Cancer Center. He previously held faculty positions at the University of Texas Health Science Center at San Antonio and Georgetown University.

Zellars’ research focuses on the safety and efficacy of radiation for the treatment of breast cancer. He also does research into health care disparities in African-American women who typically have more severe radiation toxicities. He also founded the Cancer in the Under-Privileged, Indigent or Disadvantaged Summer Fellowship, which exposes first-year medical students who have a demonstrated interest in serving disadvantaged populations to the specialty of oncology.

YOU MAY BE INTERESTED IN

The long-awaited results from the RASolute 302 trial—a phase III clinical trial evaluating daraxonrasib, a RAS inhibitor, for the treatment of patients with previously treated, metastatic pancreatic ductal adenocarcinoma—have been read out. 
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login